Article

Anxiety and depression associated with migraine: Influence on migraine subjects' disability and quality of life, and acute migraine management

Department of Evaluation and Treatment of Pain, University Teaching Hospital, Hospital Pasteur, 06602 Nice, France.
Pain (Impact Factor: 5.84). 12/2005; 118(3):319-26. DOI: 10.1016/j.pain.2005.09.010
Source: PubMed

ABSTRACT Anxiety and depression are reported to be frequently associated with migraine but how they impact on migraine-related disability, migraine subjects' quality of life, and medical and therapeutic management of migraine attacks has not been investigated. FRAMIG 3 is a nation-wide population-based postal survey carried out in France according to the 2004 international classification of headache disorders. Subjects who had had migraine attacks during the last 3 months (subjects with 'active migraine', N = 1957) were analysed for migraine-related disability (MIDAS score), quality of life (SF-12 questionnaire), and anxiety and depression (Hospital Anxiety and Depression Scale [HADS]) in comparison with non-migraine subjects (N = 8287). Survey results indicate that 50.6% of subjects with active migraine were anxious and/or depressive (28.0% had anxiety alone, 3.5% depression alone, and 19.1% both anxiety and depression; P < or = 0.01 versus non-migraine subjects for anxiety alone and combined anxiety and depression, NS for depression alone). Although, migraine-associated anxiety and depression do not appear to influence the drugs taken by migraine subjects for the acute treatment of migraine attacks, perceived treatment efficacy and satisfaction with treatment are lower in subjects with anxiety alone or combined with depression than in subjects with neither anxiety nor depression. Anxiety and depression should be systemically looked for and cared for in subjects consulting for migraine.

1 Follower
 · 
92 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Omega-3 and omega-6 fatty acids are precursors of bioactive lipid mediators posited to modulate both physical pain and psychological distress. In a randomized trial of 67 subjects with severe headaches, we recently demonstrated that targeted dietary manipulation-increasing omega-3 fatty acids with concurrent reduction in omega-6 linoleic acid (the H3-L6 intervention)-produced major reductions in headache compared with an omega-6 lowering (L6) intervention. Because chronic pain is often accompanied by psychological distress and impaired health-related quality of life (HRQOL), we used data from this trial to examine whether the H3-L6 intervention favorably impacted these domains. Additionally, we examined the effect of the interventions on the number of cases with substantial physical or mental impairments as defined by cutoff values in the Brief Symptom Inventory (BSI-18), Medical Outcomes Study Short Forms 12 (SF-12), Headache Impact Test (HIT-6), and the number of headache days per month. In the intention-to-treat analysis, participants in the H3-L6 group experienced statistically significant reductions in psychological distress (BSI-18 mean difference: -6.56; 95% confidence interval [CI]: -11.43 to -1.69) and improvements in SF-12 mental (mean difference: 6.01; 95% CI: 0.57 to 11.45) and physical (mean difference: 6.65; 95% CI: 2.14 to 11.16) health summary scores. At 12 weeks, the proportion of subjects experiencing substantial impairment according to cutoff values in the BSI-18, SF-12 physical, HIT-6, and headache days per month was significantly lower in the H3-L6 group. Dietary manipulation of n-3 and n-6 fatty acids, previously shown to produce major improvements in headache, was found to also reduce psychological distress and improve HRQOL and function.
    Pain 04/2015; 156(4). DOI:10.1097/01.j.pain.0000460348.84965.47 · 5.84 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: L’éducation thérapeutique (ETP) pour les patients migraineux s’adresse avant tout à ceux qui présentent une migraine chronique ou sont à risque de chronicisation ou d’abus d’usage d’antalgiques. La mise au point d’un tel programme relève d’une méthodologie stricte, selon le cahier des charges national publié par l’INPES (Institut national pour l’éducation à la santé) et la HAS (Haute Autorité de santé), soumis ensuite à une procédure d’autorisation par l’ARS (Agence régionale de santé). L’objectif est ici de proposer un modèle organisationnel des diverses étapes d’un programme d’ETP selon une démarche clinique clairement établie. Le recueil des données de la maladie migraineuse se fait de façon prospective sur six mois grâce à un agenda, avec évaluation régulière du retentissement émotionnel et fonctionnel. Les étapes sont ensuite l’élaboration d’un diagnostic éducatif, la définition d’un programme personnalisé, la mise en oeuvre de séances collectives selon un programme pluridisciplinaire, puis l’évaluation individuelle finale à trois et six mois. L’objectif du programme est de permettre aux patients d’acquérir des compétences de vigilance, d’autoévaluation, d’adaptation et d’autosoins, afin de diminuer la fréquence et la sévérité des crises, de mieux gérer celles-ci lorsqu’elles surviennent, en particulier l’usage des traitements antalgiques, et d’améliorer la qualité de vie, y compris en période intercritique.
    Douleur et Analgésie 12/2011; 24(4). DOI:10.1007/s11724-011-0271-7 · 0.09 Impact Factor